218 related articles for article (PubMed ID: 2231218)
1. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia.
Ferrazzini G; Klein J; Sulh H; Chung D; Griesbrecht E; Koren G
J Pediatr; 1990 Nov; 117(5):823-6. PubMed ID: 2231218
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
Levinsen M; Shabaneh D; Bohnstedt C; Harila-Saari A; Jonsson OG; Kanerva J; Lindblom A; Lund B; Andersen EW; Schmiegelow K;
Eur J Haematol; 2012 Jan; 88(1):78-86. PubMed ID: 21854453
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of sulfadimethoxine and sulfamethoxazole in combination with trimethoprim after intravenous administration to healthy and pneumonic pigs.
Mengelers MJ; Van Gogh ER; Kuiper HA; Pijpers A; Verheijden JH; Van Miert AS
J Vet Pharmacol Ther; 1995 Aug; 18(4):243-53. PubMed ID: 8583537
[TBL] [Abstract][Full Text] [Related]
4. Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole.
Kwon OC; Lee JS; Kim YG; Lee CK; Yoo B; Hong S
Clin Rheumatol; 2018 Dec; 37(12):3215-3220. PubMed ID: 29383453
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate.
Watts CS; Sciasci JN; Pauley JL; Panetta JC; Pei D; Cheng C; Christensen CM; Mikkelsen TS; Pui CH; Jeha S; Relling MV
J Pediatr Hematol Oncol; 2016 Aug; 38(6):449-52. PubMed ID: 27322715
[TBL] [Abstract][Full Text] [Related]
6. Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients.
Skoloda D; Newman M; Norman H; Ziggas JE; Ambinder RF
JCO Oncol Pract; 2024 May; 20(5):673-677. PubMed ID: 38382007
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction.
Paap CM; Nahata MC
DICP; 1989 Sep; 23(9):646-54. PubMed ID: 2678767
[TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
[TBL] [Abstract][Full Text] [Related]
9. Prescriptions for a toxic combination: use of methotrexate plus trimethoprim-sulfamethoxazole in the United States.
Davis SA; Krowchuk DP; Feldman SR
South Med J; 2014 May; 107(5):292-3. PubMed ID: 24937727
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children.
Autmizguine J; Melloni C; Hornik CP; Dallefeld S; Harper B; Yogev R; Sullivan JE; Atz AM; Al-Uzri A; Mendley S; Poindexter B; Mitchell J; Lewandowski A; Delmore P; Cohen-Wolkowiez M; Gonzalez D;
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084742
[TBL] [Abstract][Full Text] [Related]
11. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioavailability of trimethoprim-sulfamethoxazole in alpacas.
Chakwenya J; Lakritz J; Tyler J; Fales WH; James-Kracke M; Smith K; Holle J
J Vet Pharmacol Ther; 2002 Oct; 25(5):321-7. PubMed ID: 12423221
[TBL] [Abstract][Full Text] [Related]
13. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis.
Rungoe C; Malchau EL; Larsen LN; Schroeder H
Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218
[TBL] [Abstract][Full Text] [Related]
14. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
Weinthal J; Frost JD; Briones G; Cairo MS
J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia.
Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K
Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129
[TBL] [Abstract][Full Text] [Related]
16. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
[TBL] [Abstract][Full Text] [Related]
17. Influence of co-trimoxazole on methotrexate pharmacokinetics in children with acute lymphoblastic leukemia.
Beach BJ; Woods WG; Howell SB
Am J Pediatr Hematol Oncol; 1981; 3(2):115-9. PubMed ID: 6975580
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
[TBL] [Abstract][Full Text] [Related]
19. Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
Kesner JM; Yardman-Frank JM; Mercier RC; Wong CS; Walker SE; Argyres DP; Vilay AM
Blood Purif; 2014; 38(3-4):195-202. PubMed ID: 25531772
[TBL] [Abstract][Full Text] [Related]
20. Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma.
Wang SF; Huang KW; Chou YC; Lee HC; Wu PK; Chen WM; Hung GY; Chang YL
Cancer Med; 2023 Jun; 12(11):12354-12364. PubMed ID: 37062070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
